Assignee
SHAPERON INC
KR·1 granted patent·11 pending applications·0 citations·filing 2017–2024
Top patents by PatentIndex Score
12 records- 0161US2025084170A1Bispecific humanized single domain antibody to pd-l1 and cd47, and use thereofSHAPERON INC·Filed 2024·Application pending·0 cites
- 0259US2025099487A1Composition for preventing or treating pulmonary fibrosis, comprising taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredientSHAPERON INC·Filed 2024·Application pending·0 cites
- 0352US2025134909A1Gel composition for prevention or treatment of atopic dermatitisSHAPERON INC·Filed 2022·Application pending·0 cites
- 0452US2025134910A1Composition for treating coronavirus disease 2019 (covid-19) containing taurodeoxycholic acid or pharmaceutically acceptable salt thereof and antiviral agent as active ingredientsSHAPERON INC·Filed 2022·Application pending·0 cites
- 0551US2025000877A1Composition containing taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredient for preventing or treating viral infectious diseasesSHAPERON INC·Filed 2022·Application pending·0 cites
- 0649US2024391948A1Novel compound that inhibits tnf-alpha generation and inflammasome activity and preparation method thereforSHAPERON INC·Filed 2022·Application pending·0 cites
- 0749US2025262225A1Composition for treatment of covid-19 comprising taurodeoxycholic acid or pharmaceutically acceptable salt thereof as active ingredientSHAPERON INC·Filed 2022·Application pending·0 cites
- 0848US9855283B2Composition comprising GPCR19 agonist as an active ingredient for preventing or treating allergic dermatitisSHAPERON INC·Filed 2017·Granted Jan 2, 2018·0 cites·11 claims
- 0948US2024228670A9Bispecific single domain antibody to pd-l1 and cd47 and use thereofSHAPERON INC·Filed 2022·Application pending·0 cites
- 1047US2024228622A9Single domain antibody against pd-l1 and use thereofSHAPERON INC·Filed 2022·Application pending·0 cites
- 1147US2024228613A9Single domain antibody against cd47 and use thereofSHAPERON INC·Filed 2022·Application pending·0 cites
- 1240US2021386761A1Composition for preventing or treating inflammatory bowel disease, containing, as active ingredient, taurodeoxycholic acid or pharmaceutically acceptable salt thereofSHAPERON INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →